Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE: PRO)
Health Care · Pharmaceuticals · MA
MAD—
— today · — 1Y
Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE: PRO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $155.42M.
trading between 1.22K and 1.59K.
Tweenvest scores Societe de Promotion Pharmaceutique du Maghreb S.A. across four factors: quality 79/100, value 38/100, growth 36/100, dividend 97/100. Its strongest factor is dividend.
PRO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $155.42M
- Revenue (TTM)
- $109.28M
- P/E
- —
- EPS
- —
- Dividend yield
- 2.03%
- Beta (5Y)
- -0.10
- 52-week high
- MAD1,589.00
- 52-week low
- MAD1,223.00
- Avg volume (3M)
- —
- Shares outstanding
- 1.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhaoke Ophthalmology LimitedSEHK: 6622 | $158.23M | HK$2.27 | -8.65% |
| TerrAscend Corp.TSX: TSND | $157.10M | CA$0.73 | -3.33% |
| AGP LimitedKASE: AGP | $156.49M | PKRs155.48 | +2.42% |
| Cenra Inc.TWSE: 3716 | $155.60M | NT$34.15 | +0.74% |
| Anlon Healthcare LimitedNSEI: AHCL | $154.38M | Rs28.11 | -14.46% |
| Jagsonpal Pharmaceuticals LimitedNSEI: JAGSNPHARM | $153.68M | Rs225.60 | -2.65% |
| Fermenta Biotech LimitedBSE: 506414 | $153.31M | Rs517.50 | -6.14% |
| Mayne Pharma Group LimitedASX: MYX | $152.01M | AU$2.66 | -6.67% |
Figures last refreshed Oct 11, 2026.